HERVolution Therapeutics: Valuation, Funding & Investors
HERVolution Therapeutics is a biotechnology company specializing in the development of novel immunotherapies that harness the immune system to target HERV antigens from the dark genome. The company's innovative approach aims to treat cancer, metabolic diseases, and other aging-related conditions by advancing its pipeline of off-the-shelf therapeutic assets.
Leadership & Board
- Current Number of Employees
- 33
- Current LinkedIn Followers
- 3,095
Latest Estimated Valuation
- Total Amount Raised
- $12M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $12M
- Latest Funding Round
- Series A
Company Momentum
PositiveHERVolution Therapeutics LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
HERVolution Therapeutics had 33 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
HERVolution Therapeutics had 3,095 followers as of November 16, 2026. The number of followers increased by 30 (0.98%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series A | $11.70M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Serum Institute of India | Series A |
| European Innovation Council Fund | Series A |
Similar Companies
A snapshot of private companies similar to HERVolution Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis









